Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial (2010)
- Authors:
- USP affiliated authors: PEREIRA, CARLOS ALBERTO DE BRAGANCA - IME ; HOUNIE, ANA GABRIELA - FM ; MIGUEL FILHO, EURIPEDES CONSTANTINO - FM ; DINIZ, JULIANA BELO - FM ; DAINESI, SONIA MANSOLDO - FM
- Unidades: IME; FM
- DOI: 10.1177/0269881108099423
- Subjects: PSIQUIATRIA; ANÁLISE ESTATÍSTICA DE DADOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of Pharmacology
- ISSN: 0269-8811
- Volume/Número/Paginação/Ano: v. 24, n. 3, p. 297-307, 2010
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
DINIZ, Juliana Belo et al. Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial. Journal of Pharmacology, v. 24, n. 3, p. 297-307, 2010Tradução . . Disponível em: https://doi.org/10.1177/0269881108099423. Acesso em: 19 abr. 2024. -
APA
Diniz, J. B., Shavitt, R. G., Pereira, C. A. de B., Hounie, A. G., Pimentel, I., Koran, L. M., et al. (2010). Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial. Journal of Pharmacology, 24( 3), 297-307. doi:10.1177/0269881108099423 -
NLM
Diniz JB, Shavitt RG, Pereira CA de B, Hounie AG, Pimentel I, Koran LM, Dainesi SM, Miguel EC. Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial [Internet]. Journal of Pharmacology. 2010 ; 24( 3): 297-307.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1177/0269881108099423 -
Vancouver
Diniz JB, Shavitt RG, Pereira CA de B, Hounie AG, Pimentel I, Koran LM, Dainesi SM, Miguel EC. Quetiapine versus clomipramine in the augmentation of selective serotonin reuptake inhibitors for the treatment of obsessive-compulsive disorder: a randomized, open-label trial [Internet]. Journal of Pharmacology. 2010 ; 24( 3): 297-307.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1177/0269881108099423 - Sequential allocation to balance prognostic factors in a psychiatric clinical trial
- The impact of trauma and post-traumatic stress disorder on the treatment response of patients with obsessive-compulsive disorder
- Transtornos do espectro obsessivo-compulsivo e febre reumática: um estudo de transmissão familiar
- Level of insight and clinical features of obsessive-compulsive disorder with and without body dysmorphic disorder
- The use of Yale-Brown Obsessive-Compulsive Scale: new views of an old measure
- Notice of Retraction and Replacement. Lopes et al. Gamma ventral capsulotomy for obsessive-compulsive disorder: a randomized [Carta]
- Quetotaxia dorsal e tagmatização em actinotrichida (Acariformes)
- Quantifying dimensional severity of obsessive-compulsive disorder for neurobiological research
- Comorbid Body Dysmorphic Disorder is a Predictor of Worse Treatment Response to Sequential Pharmacological Treatments in Obsessive-Compulsive Disorder
- Association study between the-62A/T NFKBIL1 polymorphism and obsessive-compulsive disorder
Informações sobre o DOI: 10.1177/0269881108099423 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
